TrialBMJ open2025

Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a randomised, double-blind, placebo-controlled trial.

Caroline Nørgaard-Pedersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.